These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8138664)

  • 1. Tumor markers in the blood of preoperative digestive cancer patients.
    Bojan O; Bara A; Daicoviciu D; Bologa S; Duca S
    Int J Biol Markers; 1993; 8(4):244-5. PubMed ID: 8138664
    [No Abstract]   [Full Text] [Related]  

  • 2. [History of tumor markers for cancers of the digestive system].
    Buzás GM
    Orv Hetil; 2013 May; 154(21):810-9. PubMed ID: 23692875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
    Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
    Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms].
    Marchei P; Cifaldi L; De Benedetto A; Santini D; Manna A; Trasatti L; Marchei GG; Reale MG
    G Ital Oncol; 1990; 10(4):121-4. PubMed ID: 2093080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective investigation of tumor markers and risk assessment in early cancer screening.
    Kobayashi T; Kawakubo T
    Cancer; 1994 Apr; 73(7):1946-53. PubMed ID: 8137222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
    Jovin G; Stănel I; Popovici I; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of CA 72.4 serum levels in gastrointestinal diseases.
    Piantino P; Taccone W; Fusaro A; Daziano E; Polloni R; Mosso R
    Int J Biol Markers; 1990; 5(2):77-80. PubMed ID: 2283481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in blood sialic acid levels associated with cancer chemotherapy].
    Nakazawa I; Ouchi E
    Rinsho Byori; 1983 Mar; Suppl 54():150-7. PubMed ID: 6887569
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
    Patel PS; Raval GN; Rawal RR; Patel GH; Balar DB; Shah PM; Patel DD
    Cancer Lett; 1994 Jul; 82(2):129-33. PubMed ID: 8050082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of serum markers in the diagnosis and management of laryngeal cancer.
    Mevio E; Benazzo M; Galioto P; Spriano P; Pizzala R
    Clin Otolaryngol Allied Sci; 1991 Feb; 16(1):90-2. PubMed ID: 2032368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M; Nayak BR
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present status of serum tumor markers in diagnosis, prognosis, and evaluation of therapy.
    Cohn SL; Lincoln ST; Rosen ST
    Cancer Invest; 1986; 4(4):305-27. PubMed ID: 2429742
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
    Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
    J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer.
    Verazin G; Riley WM; Gregory J; Tautu C; Prorok JJ; Alhadeff JA
    Dis Colon Rectum; 1990 Feb; 33(2):139-42. PubMed ID: 2298100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers CA 19-9 and CA 50 in digestive tract malignancies.
    Haglund C; Roberts PJ; Jalanko H; Kuusela P
    Scand J Gastroenterol; 1992; 27(3):169-74. PubMed ID: 1502477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Andersen JW
    Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative CA 15-3 levels in operable breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
    Iaffaioli RV; Caponigro F; Esposito G; Pagliarulo C; Deplacido S; Ungaro B; Bazzicalupo L; Frasci G; Bianco AR
    Int J Biol Markers; 1991; 6(1):21-4. PubMed ID: 1856513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biomarkers for neoplasmas in digestive organs].
    Iwasaki Y; Arai K; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1015-20. PubMed ID: 15272578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers in ovarian cancer.
    Kiricuta I; Bojan O; Munteanu S
    Arch Geschwulstforsch; 1986; 56(1):35-8. PubMed ID: 3964031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.